These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 623978)

  • 21. [Systolic intervals in dilated heart insufficiency. Influence of vasodilator treatment].
    González-Juanatey JR; Amaro Cendón A; Vega Fernández M; Gil de la Peña M
    Med Clin (Barc); 1988 Jan; 90(3):93-6. PubMed ID: 3280894
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of sildenafil on cardiac performance in patients with heart failure.
    Hirata K; Adji A; Vlachopoulos C; O'Rourke MF
    Am J Cardiol; 2005 Nov; 96(10):1436-40. PubMed ID: 16275194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of benefit of preload reduction in coronary heart disease].
    Simon H
    Med Klin (Munich); 1987 Jan; 1():6-9. PubMed ID: 3472031
    [No Abstract]   [Full Text] [Related]  

  • 24. Vasodilator therapy: its role in treatment of acute left ventricular failure and mitral regurgitation.
    Palank EA
    Mil Med; 1977 Jun; 142(6):472-4. PubMed ID: 407497
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of various peripheral vasodilators on tissue circulation in patients with cardiac insufficiency].
    Aliev EB; Almazov II; Malyshev IuM; Makhatadze LN; Zhumambaeva RM
    Ter Arkh; 1982; 54(5):122-6. PubMed ID: 7101173
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prognosis and treatment of cardiac decompensation in 1987].
    Pierard L
    Rev Med Liege; 1987 May; 42(9):396-402. PubMed ID: 3602757
    [No Abstract]   [Full Text] [Related]  

  • 27. [Vasodilator agents in the therapy of cardiac insufficiency].
    ZFA (Stuttgart); 1980 Mar; 56(8):565-6. PubMed ID: 7415501
    [No Abstract]   [Full Text] [Related]  

  • 28. Vasodilator therapy in children: acute and chronic effects in children with left ventricular dysfunction or mitral regurgitation.
    Beekman RH; Rocchini AP; Dick M; Crowley DC; Rosenthal A
    Pediatrics; 1984 Jan; 73(1):43-51. PubMed ID: 6361679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Complex and asymptomatic hyperkinetic ventricular arrhythmias: a daily difficult decision problem].
    G Ital Cardiol; 1994 Oct; 24(10):1333-9. PubMed ID: 7835567
    [No Abstract]   [Full Text] [Related]  

  • 30. [Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution].
    Artese D; Albani A; Di Tomasso E
    Minerva Med; 1983 Mar; 74(13):715-22. PubMed ID: 6220231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Indices of central hemodynamics in congestive heart failure caused by heart valve lesions and its treatment with arteriolar and arteriovenous vasodilators].
    Marshutin NA
    Revmatologiia (Mosk); 1984; (2):57-61. PubMed ID: 6382548
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect and benefit of afterload reduction in coronary heart disease].
    Lossnitzer K
    Med Klin (Munich); 1987 Jan; 1():9-14. PubMed ID: 3472032
    [No Abstract]   [Full Text] [Related]  

  • 33. Vasodilator therapy for cardiac failure in pediatric practice.
    Rao PS
    Indian J Pediatr; 1982; 49(401):843-8. PubMed ID: 7182361
    [No Abstract]   [Full Text] [Related]  

  • 34. [Vasodilators: treatment of heart failure].
    Kumada T
    Nihon Naika Gakkai Zasshi; 1994 Jan; 83(1):64-9. PubMed ID: 9132456
    [No Abstract]   [Full Text] [Related]  

  • 35. [Role of nitroglycerin for injection in comparison with other vasodilators in the treatment of cardiac failure of ischemic origin].
    Francoual M
    Nouv Presse Med; 1979 Jan; 8(4):293-6. PubMed ID: 122024
    [No Abstract]   [Full Text] [Related]  

  • 36. Heart rate reduction: it is not just for ventricles anymore.
    Borlaug BA
    J Am Coll Cardiol; 2013 Nov; 62(21):1986-1989. PubMed ID: 23933537
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vasodilator treatment of left ventricular insufficiency in the acute stage of myocardial infarction].
    Fauvel JM; Donzeau JP; Bounhoure JP; Bernadet P; Calazel P
    Arch Mal Coeur Vaiss; 1977 Aug; 70(8):825-32. PubMed ID: 409363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heart failure: from physiopathology to treatment. II. Treatment].
    Batlouni M
    Arq Bras Cardiol; 1991 Aug; 57(2):151-67. PubMed ID: 1823774
    [No Abstract]   [Full Text] [Related]  

  • 39. Recent advances in vasodilator therapy. Part I: physiologic correlations.
    Aranda JM; Linares E; Hernández-López E; Cintrón G; Song S
    Bol Asoc Med P R; 1981 Jan; 73(1):3-10. PubMed ID: 7020713
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of vasodilator therapy for heart failure.
    Blonder RD
    J Am Osteopath Assoc; 1979 Jun; 78(10):753-6. PubMed ID: 468597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.